[Hepatic fibrosis aggravation in nuclear autoantigenic sperm protein (NASP) mutant mice induced by concanavalin A]

Yanyan Zhang1, Hongwei Yan2, Jun Zhu1

  • 1Department of Immunology, Weifang Medical University, Weifang 261053, China.

Insights

Nuclear autoantigenic sperm protein (NASP) gene mutation worsens liver fibrosis in mice by increasing tumor necrosis factor-alpha (TNF-α) and altering T lymphocyte subsets, promoting hepatic stellate cell activation.

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • Liver fibrosis is a significant health concern.
  • Nuclear autoantigenic sperm protein (NASP) role in liver fibrosis is not well understood.

Purpose of the Study:

  • To investigate the effect of nuclear autoantigenic sperm protein (NASP) gene mutation on concanavalin A (ConA)-induced liver fibrosis in mice.
  • To elucidate the underlying mechanisms of NASP gene mutation in liver fibrosis.

Main Methods:

  • Established a mouse model of liver fibrosis using ConA injection.
  • Assessed histopathological changes, collagen deposition, and alpha-smooth muscle actin (α-SMA) expression.
  • Measured serum liver enzymes (ALT, AST), inflammatory cytokines (TNF-α, IFN-γ), and hepatic gene expression (Col1, Col3).
  • Analyzed T lymphocyte subsets in liver tissue using flow cytometry.

Main Results:

  • NASP mutant mice showed aggravated liver fibrosis with increased collagen deposition and α-SMA expression compared to wild-type mice.
  • Significantly elevated serum ALT and TNF-α levels were observed in NASP mutant mice.
  • A marked decrease in CD4+CD44hi T lymphocyte subsets within the liver tissue of NASP mutant mice.

Conclusions:

  • Mutation of the NASP gene exacerbates liver fibrosis in mice.
  • This exacerbation is mediated by increased TNF-α release, altered liver T lymphocyte populations, and enhanced hepatic stellate cell activation.

Related Concept Videos